You are here
CIMAB to distribute two North-American products to improve assisted conception
The Centre of Male Infertility and Analysis of Barcelona (CIMAB), a spin-off of the Autonomous University of Barcelona (UAB), has closed a distribution deal with American company DxNow for its Fertile™ and Fertile Plus™ products.
Given the rise in cases of male infertility, DxNow has searched for solutions to improve the results of assisted reproduction procedures by using techniques that sort sperm with the best mobility and morphology. This way, there is no need to use centrifugation methods, which can damage sperm, and there is a boost in assisted-conception success rates.
Fertile™ and Fertile Plus™ were presented this year at the Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) and will later be distributed by CIMAB, which has also signed research agreements with the US company to develop other innovative products.
Photo: Dr Agustín García Peiró, founder and director of the CIMAB